Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: A systematic review of the epidemiological studies

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 331-345

  Labreuche, Julien ^a,b   Touboul, Pierre Jean ^a,b   Amarenco, Pierre ^a,b  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Carotid intima media thickness; Lipid; Stroke; Triglyceride

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; HEART INFARCTION; HEMORRHAGIC STROKE; HUMAN; HYPERCHOLESTEROLEMIA; INTERNAL CAROTID ARTERY; LONGITUDINAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; STROKE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA;

EID: 62649107868     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.040     Document Type: Review

References (85)

1. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
2. Lewington S., Whitlock G., Clarke R., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370 (2007) 1829-1839
3. Amarenco P., and Steg P.G. The paradox of cholesterol and stroke. Lancet 370 (2007) 1803-1804
4. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 78-1267 [Erratum in: Lancet; 2005; 366:1358]
5. Amarenco P., Bogousslavsky J., Callahan III A., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
6. Amarenco P., Labreuche J., and Touboul P.J. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis 196 (2008) 489-496
7. Rubins H.B., Robins S.J., Collins D., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341 (1999) 410-418
8. Bloomfield Rubins H., Davenport J., Babikian V., et al. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 103 (2001) 2828-2833
9. Patel A., Barzi F., Jamrozik K., et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110 (2004) 2678-2686
10. Hokanson J.E., and Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3 (1996) 213-219
11. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., and Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467
12. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9 (1987) 1-30
13. Bansal S., Buring J.E., Rifai N., et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007) 309-316
14. Iso H., Sato S., Kitamura A., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38 (2007) 1744-1751
15. Shearman A.M., Cooper J.A., Kotwinski P.J., et al. Estrogen receptor alpha gene variation and the risk of stroke. Stroke 36 (2005) 2281-2282
16. Psaty B.M., Anderson M., Kronmal R.A., et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: the cardiovascular health study. J Am Geriatr Soc 52 (2004) 1639-1647
17. Shahar E., Chambless L.E., Rosamond W.D., et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 34 (2003) 623-631
18. Tanne D., Koren-Morag N., Graff E., and Goldbourt U. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) registry: high triglycerides constitute an independent risk factor. Circulation 104 (2001) 2892-2897
19. Simons L.A., Simons J., Friedlander Y., and McCallum J. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis 159 (2001) 201-208
20. Wannamethee S.G., Shaper A.G., and Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 31 (2000) 1882-1888
21. Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27 (1996) 63-68
22. Njolstad I., Arnesen E., and Lund-Larsen P.G. Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark study. Circulation 94 (1996) 2877-2882
23. Lindenstrom E., Boysen G., and Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 309 (1994) 11-15
24. Haheim L.L., Holme I., Hjermann I., and Leren P. Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke 24 (1993) 1484-1489
25. Aronow W.S., Gutstein H., Lee N.H., and Edwards M. Three-year follow-up of risk factors correlated with new atherothrombotic brain infarction in 708 elderly patients. Angiology 39 (1988) 563-566
26. Lapidus L., Bengtsson C., Lindquist O., Sigurdsson J.A., and Rybo E. Triglycerides--main lipid risk factor for cardiovascular disease in women?. Acta Med Scand 217 (1985) 481-489
27. Rhoads G.G., and Feinleib M. Serum triglyceride and risk of coronary heart disease, stroke, and total mortality in Japanese-American men. Arteriosclerosis 3 (1983) 316-322
28. Salonen J.T., Puska P., Tuomilehto J., and Homan K. Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland. Stroke 13 (1982) 327-333
29. Gordon T., Kannel W.B., Castelli W.P., and Dawber T.R. Lipoproteins, cardiovascular disease, and death the Framingham study. Arch Intern Med 141 (1981) 1128-1131
30. Amarenco P., Labreuche J., Elbaz A., et al. Blood lipids in brain infarction subtypes. Cerebrovasc Dis 22 (2006) 101-108
31. Patel A., Woodward M., Campbell D.J., et al. Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. Eur Heart J 26 (2005) 1910-1915
32. Tokuda Y., and Stein G.H. Serum lipids as protective factors for subarachnoid hemorrhage. J Clin Neurosci 12 (2005) 538-541
33. Milionis H.J., Liberopoulos E., Goudevenos J., et al. Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. Int J Cardiol 99 (2005) 269-275
34. Laloux P., Galanti L., and Jamart J. Lipids in ischemic stroke subtypes. Acta Neurol Belg 104 (2004) 13-19
35. Bowman T.S., Sesso H.D., Ma J., et al. Cholesterol and the risk of ischemic stroke. Stroke 34 (2003) 2930-2934
36. Chen C.H., Eng H.L., Chang C.J., et al. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. J Lab Clin Med 142 (2003) 100-105
37. Sacco R.L., Benson R.T., Kargman D.E., et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan stroke study. JAMA 285 (2001) 2729-2735
38. Shimo-Nakanishi Y., Urabe T., Hattori N., et al. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke 32 (2001) 1481-1486
39. Ahmed E., Trifunovic J., Stegmayr B., Hallmans G., and Lefvert A.K. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study. Stroke 30 (1999) 2541-2546
40. Vasuvat A., and Towanabut S. Blood lipids, the risk factor of cerebral infarction. J Med Assoc Thai 76 (1993) 109-116
41. Sridharan R. Risk factors for ischemic stroke: a case control analysis. Neuroepidemiology 11 (1992) 24-30
42. Lindgren A., Nilsson-Ehle P., Norrving B., and Johansson B.B. Plasma lipids and lipoproteins in subtypes of stroke. Acta Neurol Scand 86 (1992) 572-578
43. Woo J., Lau E., Lam C.W., et al. Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke 22 (1991) 203-208
44. Cardellini M., Marini M.A., Frontoni S., et al. Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab 292 (2007) E347-E352
45. Hayashi Y., Okumura K., Matsui H., et al. Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism 56 (2007) 608-613
46. Norata G.D., Raselli S., Grigore L., et al. Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38 (2007) 2844-2846
47. Yokoyama H., Kuramitsu M., Kanno S., et al. Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. Diab Res Clin Pract 75 (2007) 200-206
48. Behre C.J., Brohall G., Hulthe J., Wikstrand J., and Fagerberg B. Are serum adiponectin concentrations in a population sample of 64-year-old Caucasian women with varying glucose tolerance associated with ultrasound-assessed atherosclerosis?. J Intern Med 260 (2006) 238-244
49. Junyent M., Cofan M., Nunez I., Gilabert R., Zambon D., and Ros E. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 26 (2006) 1107-1113
50. Park J.S., Park J., Kim C.S., et al. Relationship of low-density lipoprotein particle size to insulin resistance and intima-media thickness in nondiabetic Koreans. Metabolism 55 (2006) 1610-1615
51. Tsouli S.G., Kiortsis D.N., Xydis V., et al. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia. Angiology 57 (2006) 615-622
52. Czernichow S., Bertrais S., Blacher J., et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular study. Am J Hypertens 18 (2005) 1154-1160
53. Kawamoto R., Tomita H., Oka Y., Ohtsuka N., and Kamitani A. Metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. J Atheroscler Thromb 12 (2005) 268-275
54. Keech A.C., Grieve S.M., Patel A., et al. Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy. Diab Med 22 (2005) 1558-1565
55. Paramo J.A., Beloqui O., Roncal C., Benito A., and Orbe J. Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease. Haematologica 89 (2004) 1226-1231
56. Tremollieres F.A., Bauvin E., Cigagna F., et al. Association of cardiovascular risk factors with intima-media thickness of the carotid arteries in early postmenopausal women. Menopause 11 (2004) 323-330
57. Oren A., Vos L.E., Uiterwaal C.S., Grobbee D.E., and Bots M.L. Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) study. Arch Intern Med 163 (2003) 1787-1792
58. Sramek A., Reiber J.H., Baak-Pablo R., Sturk A., and Rosendaal F.R. Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery. J Thromb Haemost 1 (2003) 374-379
59. Velmurugan K., Deepa R., Ravikumar R., et al. Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in Type 2 diabetic patients in south India. Diab Med 20 (2003) 455-461
60. De Michele M., Panico S., Iannuzzi A., et al. Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke 33 (2002) 2923-2928
61. Urbina E.M., Srinivasan S.R., Tang R., et al. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol 90 (2002) 953-958
62. Bokemark L., Wikstrand J., Attvall S., et al. Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). J Intern Med 249 (2001) 59-67
63. Ciccone M., Vettor R., Pannacciulli N., et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 25 (2001) 805-810
64. Davis P.H., Dawson J.D., Riley W.A., and Lauer R.M. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation 104 (2001) 2815-2819
65. Simon E., Gariepy J., Cogny A., et al. Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima-media thickening in asymptomatic men at risk for cardiovascular disease. Atherosclerosis 159 (2001) 193-200
66. Stensland-Bugge E., Bonaa K.H., and Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromso study. Atherosclerosis 154 (2001) 437-448
67. Zanchetti A., Crepaldi G., Bond M.G., et al. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group. J Hypertens 19 (2001) 79-88
68. Fukumoto M., Shoji T., Emoto M., et al. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 20 (2000) 703-707
69. Hanefeld M., Koehler C., Schaper F., et al. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 144 (1999) 229-235
70. Hung J., McQuillan B.M., Nidorf M., Thompson P.L., and Beilby J.P. Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population. Arterioscler Thromb Vasc Biol 19 (1999) 1969-1974
71. Sakurabayashi T., Fujimoto M., Takaesu Y., et al. Association between plasma homocysteine concentration and carotid atherosclerosis in hemodialysis patients. Jpn Circ J 63 (1999) 692-696
72. Gariepy J., Salomon J., Denarie N., et al. Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort: the AXA Study. Arterioscler Thromb Vasc Biol 18 (1998) 584-590
73. Zanchetti A., Bond M.G., Hennig M., et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 16 (1998) 949-961
74. el-Barghouti N., Elkeles R., Nicolaides A., et al. The ultrasonic evaluation of the carotid intima-media thickness and its relation to risk factors of atherosclerosis in normal and diabetic population. Int Angiol 16 (1997) 50-54
75. Fujii K., Abe I., Ohya Y., et al. Association between hyperinsulinemia and intima-media thickness of the carotid artery in normotensive men. J Hypertens 15 (1997) 167-172
76. Lassila H.C., Tyrrell K.S., Matthews K.A., Wolfson S.K., and Kuller L.H. Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke 28 (1997) 513-517
77. Bonithon-Kopp C., Touboul P.J., Berr C., et al. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 16 (1996) 310-316
78. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke 27 (1996) 224-231
79. Wei M., Gonzalez C., Haffner S.M., O'Leary D.H., and Stern M.P. Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio, Texas. Association with diabetes and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 16 (1996) 1388-1392
80. Fan A.Z. Metabolic syndrome and progression of atherosclerosis among middle-aged US adults. J Atheroscler Thromb 13 (2006) 46-54
81. Wallenfeldt K., Bokemark L., Wikstrand J., Hulthe J., and Fagerberg B. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35 (2004) 2248-2252
82. Chambless L.E., Folsom A.R., Davis V., et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis risk in communities study, 1987-1998. Am J Epidemiol 155 (2002) 38-47
83. Todua F.I., Gachechiladze D.G., Balavadze M.B., and Akhvlediani M.V. Effect of atherogenic risk factors on the state of complex intima-media of common carotid artery. Kardiologiia 43 (2003) 50-53
84. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23 (2007) 75-80
85. Clarke R., Shipley M., Lewington S., et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150 (1999) 341-353